Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Expression Changes Relevant for Apoptosis in K562 Cells Co-Treated with Amifostine and Imatinib
GEO Series GSE3312. Homo sapiens. 4 samples. Type: Expression profiling by array.
Transcriptomic analysis of SRSF1 overexpression and imatinib treatment in K562 CML cell lines
GEO Series GSE140322. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Claudin-1 contributes to gastrointestinal stromal tumors (GIST) resistance to imatinib mesylate (IM) via regulation of FGFR2-mediated signaling.
GEO Series GSE296175. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
The effect of imatinib therapy on tumor associated macrophages (TAMs) in human gastrointestinal stromal tumor (GIST)
GEO Series GSE51697. Homo sapiens. 21 samples. Type: Expression profiling by array.
Gene expression profiling of Imatinib and PD166326 resistant cell lines
GEO Series GSE10382. Homo sapiens. 6 samples. Type: Expression profiling by array.
Gene expression profile of K562 human leukemia cell line after imatinib treatement
GEO Series GSE75055. Homo sapiens. 2 samples. Type: Expression profiling by array.
Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)
ClinicalTrials.gov study NCT00237120. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib
ClinicalTrials.gov study NCT00688766. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib
ClinicalTrials.gov study NCT00422825. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment
ClinicalTrials.gov study NCT03862768. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02317159. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
ClinicalTrials.gov study NCT02268435. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03228303. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Long-term Surival of GIST Patients ≥ 10 Years on Imatinib
ClinicalTrials.gov study NCT04097093. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00154349. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effects of Imatinib Mesylate in Polycythemia Vera
ClinicalTrials.gov study NCT00430066. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index
ClinicalTrials.gov study NCT02576080. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of Food on Bioavailability of Modified Release Formulations of Imatinib
ClinicalTrials.gov study NCT00420043. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Pha
ClinicalTrials.gov study NCT00538109. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility Study
ClinicalTrials.gov study NCT02363361. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.